Get started
Author

María Calbacho

Observed names: Calbacho, Maria, M Calbacho, M. Calbacho, Maria Calbacho, María Calbacho, María Calbacho Robles
Observed institutions: Universidad Complutense de Madrid, Inserm, University of Cologne, Universidad de Salamanca, University of Milan, Université de Versailles Saint-Quentin-en-Yvelines, Université Paris-Saclay, Instituto de Salud Carlos III, Hospital Universitari Arnau de Vilanova, Hospital General Universitario Gregorio Marañón, Research Institute Hospital 12 de Octubre, Spanish National Cancer Research Centre, Centre Hospitalier Universitaire de Tours, Hospital Universitario 12 De Octubre, Centre de recherche en Epidémiologie et Santé des Populations, Hospital Regional Universitario de Málaga, University Medical Center Hamburg-Eppendorf, University Hospital Cologne, Centro de Investigación Biomédica en Red de Cáncer, Centre Hospitalier de Versailles, Hospital Universitario Ramón y Cajal, Instituto de Investigación Sanitaria Gregorio Marañón, Eskişehir Osmangazi University
ORCID: 0000-0001-8106-4863
Observed ORCID: 0000-0001-8106-4863
OpenAlex ID: A5089090394
COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA)
2021 · Livio Pagano, Jon Salmanton-García, et al. · Journal of Hematology & Oncology · 316
PDF
COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey
2021 · Per Ljungman, Rafael de la Camara, et al. · Leukemia · 232
PDF
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE study
2017 · Hagop M Kantarjian, Daniel J DeAngelo, et al. · The Lancet Haematology · 217
Risk factors and outcome of COVID-19 in patients with hematological malignancies
2020 · José Luis Piñana, Rodrigo Martino, et al. · Experimental Hematology and Oncology · 155
PDF
Guideline adherence and survival of patients with candidaemia in Europe: results from the ECMM Candida III multinational European observational cohort study
2023 · Martin Hoenigl, Jon Salmanton-García, et al. · The Lancet Infectious Diseases · 152
PDF
Successful discontinuation of eltrombopag after complete remission in patients with primary immune thrombocytopenia
2014 · Tomás José González‐López, Cristina Pascual, et al. · American Journal of Hematology · 148
PDF
Axicabtagene ciloleucel compared to tisagenlecleucel for the treatment of aggressive B-cell lymphoma
2022 · Mi Kwon, Gloria Iacoboni, et al. · Haematologica · 136
PDF
Clinical course and risk factors for mortality from COVID‐19 in patients with haematological malignancies
2020 · José María Sanchez‐Pina, Mario Rodríguez Rodriguez, et al. · European Journal Of Haematology · 91
COVID-19 in vaccinated adult patients with hematological malignancies: preliminary results from EPICOVIDEHA
2021 · Livio Pagano, Jon Salmanton-García, et al. · Blood · 89
PDF
Chemotherapy or allogeneic transplantation in high-risk Philadelphia chromosome–negative adult lymphoblastic leukemia
2020 · Josep-Maria Ribera, Mireia Morgades, et al. · Blood · 85
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
2014 · Patricia Font, Javier Loscertales, et al. · Annals of Hematology · 81
Use of eltrombopag after romiplostim in primary immune thrombocytopenia
2014 · José Ramón González‐Porras, María Eva Mingot‐Castellano, et al. · British Journal of Haematology · 77
PDF
40th EASD Annual Meeting of the European Association for the Study of Diabetes
2004 · M. Veitenhansl, K. Stegner, et al. · Diabetologia · 66
Early intervention during imatinib therapy in patients with newly diagnosed chronic-phase chronic myeloid leukemia: a study of the Spanish PETHEMA group
2010 · F. Cervantes, P. Lopez-Garrido, et al. · Haematologica · 63
PDF
Chemotherapy-induced nausea and vomiting in acute leukemia and stem cell transplant patients: results of a multicenter, observational study.
2006 · Javier López-Jiménez, Eva Martín-Ballesteros, et al. · PubMed · 56
Feasibility and results of subtype-oriented protocols in older adults and fit elderly patients with acute lymphoblastic leukemia: Results of three prospective parallel trials from the PETHEMA group
2015 · Josep-Maria Ribera, Josep-Maria Ribera, et al. · Leukemia Research · 52
COVID-19 in adult acute myeloid leukemia patients: a long-term follow-up study from the European Hematology Association survey (EPICOVIDEHA)
2022 · Francesco Marchesi, Jon Salmanton-García, et al. · Haematologica · 50
PDF
Impact of COVID-19 in patients with multiple myeloma based on a global data network
2021 · J. Martinez-Lopez, G. Hernandez-Ibarburu, et al. · Blood Cancer Journal · 47
PDF
Real-life disease monitoring in follicular lymphoma patients using liquid biopsy ultra-deep sequencing and PET/CT
2023 · Ana Jiménez-Ubieto, María Poza, et al. · Leukemia · 42
PDF
Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022
2024 · Jon Salmanton-García, Francesco Marchesi, et al. · EClinicalMedicine · 35
PDF
Clofarabine‐based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience
2012 · Pere Barba, Antonia Sampol, et al. · American Journal of Hematology · 32
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post–CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey
2023 · Jaap A. van Doesum, Jon Salmanton-García, et al. · Blood Advances · 27
PDF
Successful Discontinuation of Eltrombopag after Complete Remission in Patients with Primary Immune Thrombocytopenia
2014 · Tomás José González-López, Cristina Pascual, et al. · Blood · 27
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
2021 · Rebeca Bailén, José Luis Vicario, et al. · Frontiers in Immunology · 24
Frequency, Clinical Characteristics and Outcome of Adults With Acute Lymphoblastic Leukemia and COVID 19 Infection in the First vs. Second Pandemic Wave in Spain
2021 · Josep-Maria Ribera, Mireia Morgades, et al. · Clinical Lymphoma Myeloma & Leukemia · 21
PDF
Works count: 176
Citation count: 2,825
H-index: 24
I10-index: 48
Year
Topic
Type